| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 6 | 2024 | 200 | 1.800 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 703 | 1.330 |
Why?
|
| Genomics | 6 | 2025 | 848 | 1.140 |
Why?
|
| Sequence Analysis, RNA | 5 | 2024 | 257 | 0.930 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2024 | 37 | 0.880 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 555 | 0.860 |
Why?
|
| Cell Lineage | 1 | 2024 | 321 | 0.760 |
Why?
|
| Genetics, Population | 2 | 2025 | 439 | 0.740 |
Why?
|
| Supervised Machine Learning | 1 | 2021 | 15 | 0.680 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2019 | 157 | 0.650 |
Why?
|
| Immunotherapy | 4 | 2022 | 761 | 0.640 |
Why?
|
| Immune System | 2 | 2017 | 101 | 0.560 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 179 | 0.550 |
Why?
|
| Immunity, Innate | 2 | 2019 | 463 | 0.540 |
Why?
|
| MicroRNAs | 5 | 2018 | 580 | 0.520 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2018 | 103 | 0.510 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 16 | 0.500 |
Why?
|
| Gene Expression Profiling | 6 | 2019 | 1517 | 0.500 |
Why?
|
| Polymorphism, Genetic | 2 | 2019 | 826 | 0.500 |
Why?
|
| Algorithms | 1 | 2024 | 1956 | 0.480 |
Why?
|
| Gene Expression | 4 | 2021 | 1304 | 0.460 |
Why?
|
| Biomarkers, Tumor | 4 | 2022 | 1661 | 0.450 |
Why?
|
| Precision Medicine | 5 | 2022 | 456 | 0.420 |
Why?
|
| Gene Expression Regulation | 7 | 2021 | 1980 | 0.420 |
Why?
|
| Software | 2 | 2018 | 671 | 0.400 |
Why?
|
| Computational Biology | 5 | 2021 | 581 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1133 | 0.390 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 538 | 0.370 |
Why?
|
| Neoplasms | 4 | 2021 | 3170 | 0.360 |
Why?
|
| Mice | 18 | 2024 | 12239 | 0.320 |
Why?
|
| Autoimmunity | 3 | 2024 | 191 | 0.310 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 2368 | 0.310 |
Why?
|
| Androgens | 2 | 2024 | 163 | 0.300 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3432 | 0.290 |
Why?
|
| Humans | 30 | 2025 | 93609 | 0.280 |
Why?
|
| Multifactorial Inheritance | 3 | 2025 | 202 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2024 | 2466 | 0.260 |
Why?
|
| Animals | 21 | 2024 | 28047 | 0.260 |
Why?
|
| Transfection | 1 | 2009 | 878 | 0.260 |
Why?
|
| Histocompatibility Antigens Class II | 3 | 2021 | 171 | 0.260 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 555 | 0.260 |
Why?
|
| Dendritic Cells | 3 | 2017 | 536 | 0.240 |
Why?
|
| Genetic Variation | 3 | 2024 | 1415 | 0.240 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2018 | 149 | 0.230 |
Why?
|
| Interferon Regulatory Factors | 3 | 2017 | 75 | 0.220 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2024 | 20 | 0.210 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 465 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2024 | 10 | 0.210 |
Why?
|
| Transcriptome | 3 | 2021 | 761 | 0.210 |
Why?
|
| Genome-Wide Association Study | 5 | 2024 | 1763 | 0.210 |
Why?
|
| Immune Tolerance | 2 | 2017 | 376 | 0.210 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 120 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 590 | 0.200 |
Why?
|
| Interleukin-4 | 2 | 2021 | 135 | 0.200 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1115 | 0.190 |
Why?
|
| Linkage Disequilibrium | 1 | 2024 | 478 | 0.190 |
Why?
|
| Population Health | 1 | 2023 | 33 | 0.190 |
Why?
|
| Cell Communication | 1 | 2024 | 216 | 0.190 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2021 | 49 | 0.190 |
Why?
|
| Retroviridae | 1 | 2022 | 73 | 0.180 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2024 | 236 | 0.180 |
Why?
|
| Open Reading Frames | 1 | 2021 | 113 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 2484 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2024 | 3500 | 0.170 |
Why?
|
| Receptors, Cytokine | 1 | 2021 | 31 | 0.170 |
Why?
|
| STAT6 Transcription Factor | 1 | 2021 | 30 | 0.170 |
Why?
|
| Bacteria | 3 | 2022 | 509 | 0.170 |
Why?
|
| Exome | 1 | 2021 | 141 | 0.170 |
Why?
|
| Databases, Nucleic Acid | 1 | 2021 | 45 | 0.170 |
Why?
|
| Models, Immunological | 1 | 2021 | 85 | 0.170 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2021 | 38 | 0.170 |
Why?
|
| Organoids | 1 | 2021 | 76 | 0.160 |
Why?
|
| Allografts | 1 | 2021 | 205 | 0.160 |
Why?
|
| Immunity, Humoral | 2 | 2018 | 74 | 0.160 |
Why?
|
| Leukemia | 1 | 2022 | 301 | 0.160 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 317 | 0.160 |
Why?
|
| Lipids | 1 | 2021 | 278 | 0.160 |
Why?
|
| Skin Neoplasms | 1 | 2025 | 621 | 0.160 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 300 | 0.150 |
Why?
|
| Defensins | 1 | 2019 | 5 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2021 | 1120 | 0.150 |
Why?
|
| Coronary Artery Disease | 1 | 2024 | 375 | 0.150 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1610 | 0.150 |
Why?
|
| Antigen Presentation | 3 | 2017 | 229 | 0.150 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 1275 | 0.150 |
Why?
|
| Major Histocompatibility Complex | 1 | 2019 | 86 | 0.150 |
Why?
|
| Principal Component Analysis | 1 | 2019 | 167 | 0.150 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 420 | 0.150 |
Why?
|
| Models, Biological | 4 | 2021 | 1769 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 137 | 0.140 |
Why?
|
| Phylogeny | 1 | 2024 | 1268 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 260 | 0.140 |
Why?
|
| Plasma Cells | 1 | 2018 | 84 | 0.140 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 78 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 660 | 0.140 |
Why?
|
| Germinal Center | 1 | 2018 | 62 | 0.140 |
Why?
|
| Rauscher Virus | 1 | 2017 | 8 | 0.130 |
Why?
|
| HLA-D Antigens | 1 | 2017 | 20 | 0.130 |
Why?
|
| Genome | 1 | 2020 | 407 | 0.130 |
Why?
|
| Microbiota | 1 | 2023 | 431 | 0.130 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2017 | 64 | 0.130 |
Why?
|
| Retroviridae Infections | 1 | 2017 | 43 | 0.130 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 168 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 1102 | 0.130 |
Why?
|
| Immunologic Techniques | 1 | 2017 | 24 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2017 | 337 | 0.130 |
Why?
|
| Lymphocyte Activation | 5 | 2024 | 798 | 0.120 |
Why?
|
| Th2 Cells | 2 | 2017 | 149 | 0.120 |
Why?
|
| Vaccination | 1 | 2018 | 303 | 0.120 |
Why?
|
| Intestines | 1 | 2019 | 432 | 0.120 |
Why?
|
| Mice, Inbred NOD | 3 | 2024 | 218 | 0.120 |
Why?
|
| Hypertension | 1 | 2022 | 758 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 162 | 0.120 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 891 | 0.120 |
Why?
|
| Male | 12 | 2025 | 44580 | 0.120 |
Why?
|
| Milk Hypersensitivity | 1 | 2015 | 12 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2021 | 1123 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1050 | 0.110 |
Why?
|
| Female | 12 | 2025 | 48778 | 0.110 |
Why?
|
| Butyrates | 1 | 2015 | 56 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2019 | 594 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 824 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2021 | 873 | 0.110 |
Why?
|
| RNA | 1 | 2019 | 574 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2018 | 1584 | 0.110 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2014 | 16 | 0.110 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2014 | 11 | 0.110 |
Why?
|
| Probiotics | 1 | 2015 | 92 | 0.110 |
Why?
|
| fas Receptor | 1 | 2014 | 73 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 1339 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2024 | 2122 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 800 | 0.100 |
Why?
|
| Immunity | 1 | 2014 | 153 | 0.090 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 66 | 0.090 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 319 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 48 | 0.090 |
Why?
|
| Immunomodulation | 1 | 2012 | 63 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 109 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 179 | 0.090 |
Why?
|
| Th17 Cells | 1 | 2012 | 93 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 290 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2014 | 1690 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2013 | 255 | 0.080 |
Why?
|
| Molecular Sequence Annotation | 2 | 2021 | 78 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 156 | 0.080 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 58 | 0.080 |
Why?
|
| Phenotype | 3 | 2021 | 2545 | 0.080 |
Why?
|
| Models, Genetic | 2 | 2020 | 970 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 2756 | 0.080 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 4 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2009 | 6 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 281 | 0.070 |
Why?
|
| Cell Line | 2 | 2014 | 2458 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1932 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 302 | 0.070 |
Why?
|
| Blood Pressure | 2 | 2023 | 896 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2021 | 277 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 254 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1233 | 0.070 |
Why?
|
| Protein Binding | 3 | 2018 | 1529 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2009 | 729 | 0.060 |
Why?
|
| Antibodies, Viral | 2 | 2018 | 322 | 0.060 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 279 | 0.060 |
Why?
|
| Bangladesh | 1 | 2025 | 340 | 0.050 |
Why?
|
| Gastrointestinal Tract | 2 | 2015 | 195 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2024 | 700 | 0.050 |
Why?
|
| Proteolysis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Glutens | 1 | 2023 | 86 | 0.040 |
Why?
|
| Machine Learning | 1 | 2025 | 344 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 26 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2021 | 32 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 37 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2021 | 84 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 100 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 85 | 0.040 |
Why?
|
| Symbiosis | 1 | 2022 | 128 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1735 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 885 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 124 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 214 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 283 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2022 | 235 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 691 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 392 | 0.040 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 207 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2021 | 315 | 0.040 |
Why?
|
| HLA Antigens | 1 | 2021 | 228 | 0.040 |
Why?
|
| Diet | 1 | 2023 | 461 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 246 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 1014 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2828 | 0.040 |
Why?
|
| Alleles | 1 | 2021 | 1139 | 0.030 |
Why?
|
| CD40 Antigens | 1 | 2018 | 43 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 2018 | 89 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 83 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 335 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2021 | 868 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 2493 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 296 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2018 | 264 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 304 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 1207 | 0.030 |
Why?
|
| Hepatitis B | 1 | 2017 | 77 | 0.030 |
Why?
|
| Infant | 2 | 2015 | 3220 | 0.030 |
Why?
|
| Kidney | 1 | 2021 | 1111 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 517 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2017 | 167 | 0.030 |
Why?
|
| Caseins | 1 | 2015 | 9 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2020 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2017 | 182 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 394 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1260 | 0.030 |
Why?
|
| Vero Cells | 1 | 2014 | 98 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 49 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2017 | 408 | 0.030 |
Why?
|
| Nippostrongylus | 1 | 2013 | 4 | 0.030 |
Why?
|
| Strongylida Infections | 1 | 2013 | 7 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2013 | 12 | 0.030 |
Why?
|
| Castration | 1 | 2013 | 32 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2013 | 28 | 0.030 |
Why?
|
| Receptors, Interleukin | 1 | 2013 | 38 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 360 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 52 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 27621 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2013 | 42 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 171 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1232 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 133 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2014 | 164 | 0.020 |
Why?
|
| Interleukins | 1 | 2013 | 133 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2014 | 351 | 0.020 |
Why?
|
| Cytokines | 1 | 2017 | 863 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2013 | 109 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 309 | 0.020 |
Why?
|
| Metagenome | 1 | 2013 | 116 | 0.020 |
Why?
|
| Risk Factors | 1 | 2023 | 5914 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 139 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 240 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 1003 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 712 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 460 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2013 | 454 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 69 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 334 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 129 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 292 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2014 | 962 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 306 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 580 | 0.020 |
Why?
|
| Macrophages | 1 | 2013 | 610 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 775 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7642 | 0.020 |
Why?
|
| Survival Rate | 1 | 2011 | 1951 | 0.020 |
Why?
|
| Lung | 1 | 2013 | 1365 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 823 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4266 | 0.010 |
Why?
|
| Apoptosis | 1 | 2011 | 1719 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 3833 | 0.010 |
Why?
|
| Child | 1 | 2011 | 7361 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 6936 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 9611 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 27947 | 0.010 |
Why?
|